Company & Sponsor Intelligence

Dartmouth-Hitchcock Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials15
Recruiting5
Completed9
Countries1

Therapeutic footprint

adhdalsautismdementia_otherdepressionepilepsypain_neuropathyparkinsonssubstance_use

Indexed studies

NCT04637581Wraparound for High-risk Families with Substance Use Disorders: Examining Family, Child, and Parent Outcomes
depression · United StatesNA
NCT06425029Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
epilepsy · United StatesNA
NCT06462911Epilepsy Self-Management for Spanish Speakers: HOBSCOTCH - ESPANOL
epilepsy · United StatesNA
NCT07735715HOBSCOTCH-YOUTH and Young Adults
epilepsy · United StatesNA
NCT02063984Behavioral Treatment of Adolescent Substance Use
substance_use · United StatesNA
NCT03329703Project UPLIFT for Psychogenic Non-Epileptic Seizures
epilepsy · United StatesNA
NCT05529264Human Intracranial Electrophysiology
epilepsy · United StatesNA
NCT04648553Task-Based Grounding Program
adhd · United StatesPHASE1
NCT04719403Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers
als · United StatesNA
NCT06391489HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
dementia_other · United StatesNA
NCT02084303Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI
epilepsy · United StatesNA
NCT00053690Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
depression · United StatesNA

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →